RE:RE:Whoever has listened to Francine
Well then, you must have or had a lot of shares. Assumption: You had (have) 200,000 at an average cost of $2.00CDN, then yes your claim works. You sound defeated. Why do you resign yourself to the 'all is lost' outcome? If you truly believe odds are slim for comeback you should sell half and ride out the rest. If you originally bought and added perhaps added to with conviction then see it through to the bitter or fruitful end. Hurdles are: 1. Loss of confidence in management's ability to execute flawlessly from this point and hopefully to a successful launch, which is understandable, 2. Litigation - very likely at some point due to what could be a grave protocol error 3. American protectionism. Unfortunately, for some reason the FDA has an disproportionate say in overall 'world' acceptance of a drug, even though all countries should be able to decide on their own COA. Amarin has a huge incentive to lobby thru media or dare I say it to certain decision makers within the FDA to maintain their monopoly - which BTW is suppose to be illegal in the US. I would prefer to think that is not the case but my trust level in government entities is very low, 4. The manufacture of this drug is very risky. Acasti has one supplier, in France I believe, that is willing to take on the dangerous manufacturing process. An accident (explosion) could easily happen , it has before when acetone was involved. This accident possibility will always be present. Stock will take a significant hit if it ever happened. Hopefully this will never happen but the point is, it could.